IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
Letter of Intent (“LOI”) signed to cooperate in the evaluation, research support, localization, commercialization preparation and regulatory preparation of the PressureSafe™ medical device in Japan.Collaboration addresses a significant potential market need in Japan, which includes more than 36 million people aged 65 and older and approximately 8,000 hospitals, 13,600 long-term care facilities, and 16,000+ home-visit nursing stations.Strategic collaboration combines IR-MED's infrared spectroscopy technology and proprietary algorithm with Dice Technologies' capabilities in coordinating clinical evaluation, localization and regulatory preparation activities in Japan.Clinical research and evidence-generation activities are expected to include cooperation with the Department of Plastic Surgery at Kobe University, subject to required ethics review, institutional approvals and separate written arrangements.